Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies

por Heil, Florian, Babitzki, Galina, Julien-Laferriere, Alice, Ooi, Chia-Huey, Hidalgo, Manuel, Massard, Christophe, Martinez-Garcia, Maria, Le Tourneau, Christophe, Kockx, Mark, Gerber, Peter, Rossomanno, Simona, Krieter, Oliver, Lahr, Angelika, Wild, Norbert, Harring, Suzana Vega, Lechner, Katharina
Publicado 2020

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

por Heiss, Markus M, Murawa, Pawel, Koralewski, Piotr, Kutarska, Elzbieta, Kolesnik, Olena O, Ivanchenko, Vladimir V, Dudnichenko, Alexander S, Aleknaviciene, Birute, Razbadauskas, Arturas, Gore, Martin, Ganea-Motan, Elena, Ciuleanu, Tudor, Wimberger, Pauline, Schmittel, Alexander, Schmalfeldt, Barbara, Burges, Alexander, Bokemeyer, Carsten, Lindhofer, Horst, Lahr, Angelika, Parsons, Simon L
Publicado 2010

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

por Bendell, Johanna C., Sauri, Tamara, Gracián, Antonio Cubillo, Alvarez, Rafael, López‐López, Carlos, García‐Alfonso, Pilar, Hussein, Maen, Miron, Maria‐Luisa Limon, Cervantes, Andrés, Montagut, Clara, Vivas, Cristina Santos, Bessudo, Alberto, Plezia, Patricia, Moons, Veerle, Andel, Johannes, Bennouna, Jaafar, van der Westhuizen, Andre, Samuel, Leslie, Rossomanno, Simona, Boetsch, Christophe, Lahr, Angelika, Franjkovic, Izolda, Heil, Florian, Lechner, Katharina, Krieter, Oliver, Hurwitz, Herbert
Publicado 2019